GLP-1 Telehealth Compliance: What Brand Owners Need to Know

If you run a GLP-1 program, you are in one of the most closely watched areas of consumer healthcare. Regulators, payment processors, ad platforms and journalists are all paying attention. That is not a reason to stay out. It is a reason to understand the rules before you write a single ad.

This issue walks through the main compliance areas a brand owner touches. It is written for founders, not lawyers, so treat it as a map, not legal advice. If you are using a white label GLP-1 telehealth platform and want to compare against one example, you can see how it works on Cuvo's GLP-1 page.

1. Who makes the medical decision

The core rule is simple. A licensed provider decides whether a patient is a candidate for any medication, which one and at what dose. The brand does not. Your marketing, your intake design and your sales scripts must all reflect that.

In practice this means:

  • No "guaranteed approval" or "everyone qualifies" language
  • No pressure tactics that push patients toward a specific drug
  • An intake that collects honest history, including reasons someone may not be a candidate

Cuvo states that providers make all prescribing decisions in its model. Ask any partner to put that in writing.

2. Corporate practice of medicine

Many states limit how non-physician businesses can control medical practice. A common structure pairs a management services organization with a physician-owned professional entity. The brand provides marketing and non-medical services. The medical entity provides care. Your counsel should confirm the structure for each state you serve.

3. Compounded medications

This is where many brands get into trouble. Compounded drugs are not FDA-approved, and the FDA has stated safety concerns about unapproved and compounded GLP-1 products. Compounding is governed by specific federal rules, and what is allowed depends on circumstances such as drug shortage status and patient-specific need.

The FDA's human drug compounding page is the best starting point for understanding those rules. Keep your product plan flexible. If rules or supply change, you should be able to adjust without rebuilding your business.

4. Pharmacy and shipping

Pharmacies must be licensed in the states they ship to. Temperature-sensitive medications need proper cold-chain handling. Each fill should carry traceable information such as a lot number and beyond-use date.

Cuvo lists 17 partner pharmacies, 2–8 °C cold-chain shipping typically within two business days, and lot and beyond-use date tracking. Whatever partner you use, ask for the same specifics.

5. Advertising and claims

Health advertising must be truthful and supported by evidence. For weight loss in particular:

  1. Avoid specific results or timelines.
  2. Use testimonials carefully, with consent and typical-experience context.
  3. Do not use brand-name drug names in ways that imply you sell that brand when you do not.
  4. Disclose material costs clearly.

Ad platforms and payment processors often require third-party certification before you can run telehealth or prescription offers. Cuvo says it manages LegitScript certification for partners and self-reports recent applications averaging 7 to 14 days to approval.

6. Privacy and data

Patient information is protected health information. Anyone who handles it on your behalf needs a business associate agreement. Be careful with tracking pixels and analytics on intake pages, because they can send sensitive data to third parties without you noticing.

Cuvo describes HIPAA coverage with a BAA and SOC 2 Type II controls. Your own marketing stack still needs review.

7. State-by-state variation

Telehealth rules are not uniform. Consent requirements, prescribing rules, required disclosures and even which provider types can prescribe vary white label glp-1 telehealth platform by state. A partner with 50-state regulatory monitoring helps, but you are still responsible for your brand's conduct.

The short version

GLP-1 compliance comes down to a handful of habits. Let providers decide. Treat compounding questions seriously. Use licensed pharmacies. Keep ads honest. Protect data. Check state rules with counsel. Build those habits into your process from day one, and compliance stops feeling like a brake and starts feeling like a moat.